Richard A Hansen1, Corrine I Voils2, Joel F Farley3, Benjamin J Powers2, Linda L Sanders4, Betsy Sleath3, Matthew L Maciejewski5. 1. Harrison School of Pharmacy Auburn University, AL, USA. 2. Durham VA Medical Center, NC, USA Duke University Medical, NC, USA. 3. University of North Carolina at Chapel Hill, NC, USA. 4. Duke University Medical, NC, USA. 5. Durham VA Medical Center, NC, USA Duke University Medical, NC, USA mlm34@duke.edu.
Abstract
BACKGROUND: Medication adherence is a critical aspect of managing cardiometabolic conditions, including diabetes, hypertension, dyslipidemia, and heart failure. Patients who have multiple cardiometabolic conditions and multiple prescribers may be at increased risk for nonadherence. OBJECTIVE: The purpose of this study was to examine the relationship between number of prescribers, number of conditions, and refill adherence to oral medications to treat cardiometabolic conditions. METHODS: In this retrospective cohort study, 7933 veterans were identified with 1 to 4 cardiometabolic conditions. Refill adherence to oral medications for diabetes, hypertension, and dyslipidemia was measured using an administrative claims-based continuous multiple-interval gap (CMG) that estimates the percentage of days a patient did not possess medication. We dichotomized refill adherence for each condition as a CMG ≤20% for each year of analysis. Condition-specific logistic regression models estimated the relationship between refill adherence and number of cardiometabolic conditions and number of prescribers, controlling for demographic characteristics, other comorbidities, and a count of cardiometabolic drug classes used. RESULTS: Compared with patients with 1 prescriber, antihypertensive refill adherence was lower in patients seeing ≥4 prescribers (odds ratio [OR] = 0.69; 95% CI = 0.59-0.80), but the number of cardiometabolic conditions was not a significant predictor. Antidyslipidemia refill adherence was lower in patients seeing 3 prescribers (OR = 0.80; 95% CI = 0.70-0.92) or ≥4 prescribers (OR = 0.77; 95% CI = 0.64-0.91). Conversely, antidyslipidemia refill adherence improved with the number of cardiometabolic conditions, but differences were only statistically significant for ≥3 conditions (OR = 1.31; 95% CI = 1.09-1.57). In multivariate regression models, the number of conditions and number of prescribers were not significant predictors of refill adherence in the group of patients with diabetes. CONCLUSIONS: Effective management of care and medication regimens for complex patients remains an unresolved challenge, but these results suggest that medication refill adherence might be improved by minimizing the number of prescribers involved in a patient's care, at least for hypertension and dyslipidemia.
BACKGROUND: Medication adherence is a critical aspect of managing cardiometabolic conditions, including diabetes, hypertension, dyslipidemia, and heart failure. Patients who have multiple cardiometabolic conditions and multiple prescribers may be at increased risk for nonadherence. OBJECTIVE: The purpose of this study was to examine the relationship between number of prescribers, number of conditions, and refill adherence to oral medications to treat cardiometabolic conditions. METHODS: In this retrospective cohort study, 7933 veterans were identified with 1 to 4 cardiometabolic conditions. Refill adherence to oral medications for diabetes, hypertension, and dyslipidemia was measured using an administrative claims-based continuous multiple-interval gap (CMG) that estimates the percentage of days a patient did not possess medication. We dichotomized refill adherence for each condition as a CMG ≤20% for each year of analysis. Condition-specific logistic regression models estimated the relationship between refill adherence and number of cardiometabolic conditions and number of prescribers, controlling for demographic characteristics, other comorbidities, and a count of cardiometabolic drug classes used. RESULTS: Compared with patients with 1 prescriber, antihypertensive refill adherence was lower in patients seeing ≥4 prescribers (odds ratio [OR] = 0.69; 95% CI = 0.59-0.80), but the number of cardiometabolic conditions was not a significant predictor. Antidyslipidemia refill adherence was lower in patients seeing 3 prescribers (OR = 0.80; 95% CI = 0.70-0.92) or ≥4 prescribers (OR = 0.77; 95% CI = 0.64-0.91). Conversely, antidyslipidemia refill adherence improved with the number of cardiometabolic conditions, but differences were only statistically significant for ≥3 conditions (OR = 1.31; 95% CI = 1.09-1.57). In multivariate regression models, the number of conditions and number of prescribers were not significant predictors of refill adherence in the group of patients with diabetes. CONCLUSIONS: Effective management of care and medication regimens for complex patients remains an unresolved challenge, but these results suggest that medication refill adherence might be improved by minimizing the number of prescribers involved in a patient's care, at least for hypertension and dyslipidemia.
Authors: Matthew L Maciejewski; Benjamin J Powers; Linda L Sanders; Joel F Farley; Richard A Hansen; Betsy Sleath; Corrine I Voils Journal: J Gen Intern Med Date: 2014-01-10 Impact factor: 5.128
Authors: Lisa L Cook; Richard P Golonka; Charles M Cook; Robin L Walker; Peter Faris; Shannon Spenceley; Richard Lewanczuk; Robert Wedel; Rebecca Love; Cheryl Andres; Susan D Byers; Tim Collins; Scott Oddie Journal: CMAJ Open Date: 2020-11-16
Authors: Joel F Farley; Richard A Hansen; Marisa E Domino; Mrudula Borse; Nirosha Mahendraratnam; Neepa Ray; Matthew L Maciejewski Journal: Gen Hosp Psychiatry Date: 2016-12-08 Impact factor: 3.238
Authors: Samina T Syed; Lisa K Sharp; Yoonsang Kim; Adam Jentleson; Claudia M Lora; Daniel R Touchette; Michael L Berbaum; Katie J Suda; Ben S Gerber Journal: Pharmacotherapy Date: 2016-05-28 Impact factor: 4.705
Authors: Matthew L Maciejewski; Bradley G Hammill; Elizabeth A Bayliss; Laura Ding; Corrine I Voils; Lesley H Curtis; Virginia Wang Journal: Med Care Date: 2017-04 Impact factor: 2.983
Authors: Evan S Cole; Coleman Drake; Ellen DiDomenico; Michael Sharbaugh; Joo Yeon Kim; Dylan Nagy; Gerald Cochran; Adam J Gordon; Walid F Gellad; Janice Pringle; Jack Warwick; Chung-Chou H Chang; Julie Kmiec; David Kelley; Julie M Donohue Journal: Drug Alcohol Depend Date: 2021-02-16 Impact factor: 4.492
Authors: Richard A Hansen; Natalie Hohmann; Matthew L Maciejewski; Marisa E Domino; Neepa Ray; Nirosha Mahendraratnam; Joel F Farley Journal: J Pharm Health Serv Res Date: 2017-11-20
Authors: Deborah A Taira; Brendan K Seto; James W Davis; Todd B Seto; Doug Landsittel; Wesley K Sumida Journal: J Pharm Health Serv Res Date: 2017-08-07